Wang Y, Yen FS, Zhu XG, Timson RC, Weber R, Xing C, et al
doi: 10.1093/cvr/cvz323 109 SharmaAVermaS
Post-mortem numbers of the tyrosine hydroxylase expressing DA neurons in the substantia nigra were counted

Appropriate use: During significant shortages or when branded medications are unattainable When a patient has a documented allergy or intolerance to an inactive ingredient in the FDA-approved product When a clinically justified dose or formulation is not commercially available for example, micro-dosing or alternative administration When a patient faces financial barriers and no affordable FDA-approved options are available, with documented clinical oversight and informed consent Inappropriate use: Simply for convenience or general cost-cutting without exploring other available, safer options For widespread, elective use without individualized clinical justification When used as a first-line alternative in place of available FDA-approved medications Decision-making checklist for employers: Confirm PCAB or equivalent pharmacy accreditation Require third-party testing for purity, potency, and sterility Clarify 503A vs
Step 1: Assess your needs
Were you aware of the risk of thyroid cancer with the use of this medication